Gyre Therapeutics Inc.

GYRE | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.55

-$1.86 (-29.02%)

At close: Oct 30, 2026, 4:00 PM ET

$4.76

+$0.21 (+4.62%)

Pre-market: Nov 2, 2026, 7:38 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	9.88M	17.9M	-85.48M	4.31M	-87.93M	-56.24M
Depreciation & Amortization	2.48M	1.59M	1.11M	1.13M	290K	138K
Stock-Based Compensation	7.16M	831K	7.28M	13.37M	3.41M	3.63M
Other Working Capital	17K	-4.02M	4.22M	1.11M	-5.39M	-15.91M
Other Non-Cash Items	-1.85M	-7.27M	96.68M	503K	3.89M	n/a
Deferred Income Tax	-1.11M	-1M	-1.16M	-838K	-3.89M	n/a
Change in Working Capital	-15.55M	-15.69M	7.46M	-7.8M	483K	-2.57M
Operating Cash Flow	1.01M	-3.64M	25.89M	10.68M	-83.76M	-55.05M
Capital Expenditures	-1.19M	-3.13M	-8.59M	-5M	-839K	-267K
Cash Acquisitions	30K	-1.69M	4.02M	-1.33M	n/a	n/a
Purchase of Investments	n/a	-15.47M	-15.74M	-7.48M	n/a	-97.64M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	49.03M	107.57M
Other Investing Acitivies	686K	-412K	471K	-13K	n/a	n/a
Investing Cash Flow	-474K	-19.88M	-19.76M	-13.81M	48.19M	9.66M
Debt Repayment	n/a	n/a	n/a	n/a	-6.7M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.49M	1.33M	n/a	n/a	6.7M	n/a
Financial Cash Flow	24.38M	2.1M	2.5M	n/a	49.55M	60.38M
Net Cash Flow	25.26M	-21.7M	8.33M	-5.03M	13.99M	14.99M
Free Cash Flow	-180K	-6.77M	17.31M	5.68M	-84.59M	-55.32M
Adj. Free Cash Flow	-7.34M	-7.6M	10.03M	-7.69M	-88M	-58.94M
Maintenance CapEx	n/a	-3.13M	-6.26M	n/a	-839K	n/a
Growth CapEx	-1.19M	n/a	-2.32M	-5M	n/a	-267K
Owner Earnings	1.01M	-6.77M	19.63M	10.68M	-84.59M	-55.05M